Table 3 Costs and outcomes from the probabilistic sensitivity analysis
Costs and outcomes | Mean (95% confidence interval) |
|---|---|
Cost of promotion (US$) | 3,459,154 (3,406,782–3,511,527) |
DALY without promotion | 888,657 (855,752–921,564) |
DALY with promotion | 864,596 (832,625–896,568) |
DALY averted | 24,061 (23,332–24,790) |
Deaths averted | 900 (873–927) |
Incremental cost-effectiveness ratio (US$/DALY averted) | 143.77 (137.42–150.50) |
Cases of severe pneumonia hospitalisation averted | 28,359 (27,370–29,349) |
Cost of severe pneumonia hospitalisation averted (US$) | 390,578 (252,041–508,198) |